Astrazeneca Phar

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,550.00",
    "chg": -73,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "8,623.00",
    "mcapval": "21,537.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE203A01020",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "4.78 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3825669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AstrazenecaPhar_mojoScore_3825669.png",
        "date": "2026-02-07 10:10:48",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Technical Momentum Shift Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-technical-momentum-shift-amid-mixed-signals-3815480",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AstrazenecaPhar_technicaldot_3815480.png",
        "date": "2026-02-02 08:04:04",
        "description": "Astrazeneca Pharma India Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a modest day gain of 0.97%, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential stabilisation. This article analyses the recent technical parameter changes, key momentum indicators, and how Astrazeneca’s performance compares with broader market benchmarks."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3805278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstrazenecaPhar_mojoScore_3805278.png",
        "date": "2026-01-27 10:10:35",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Gains 0.65%: 2 Key Technical Signals Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-gains-065-2-key-technical-signals-shape-weekly-trend-3803479",
        "imagepath": "",
        "date": "2026-01-24 15:07:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 21:</strong> Death Cross formation signalling bearish trend</p>\n                    <p><strong>Jan 22:</strong> Technical downgrade with Mojo Grade shifting to Sell</p>\n                    <p><strong>Jan 23:</strong> Week closes at Rs.8,305.85 (+0.65%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8,251.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.8,305.85</div><div class=\"stat-change positive\">+0.65%</div></div>\n                    <div class=\"stat..."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downgrade-3799502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstrazenecaPhar_technicaldot_3799502.png",
        "date": "2026-01-22 08:01:12",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.12%, the stock’s broader technical landscape suggests caution for investors amid weakening momentum and mixed signals from key oscillators and moving averages."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls 3.29%: Technical Weakness and Valuation Concerns Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-falls-329-technical-weakness-and-valuation-concerns-shape-the-week-3788387",
        "imagepath": "",
        "date": "2026-01-10 15:04:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Jan:</strong> Downgrade to Sell rating amid technical weakness and valuation concerns</p>\n                    <p><strong>5 Jan:</strong> Mildly bearish technical shift confirmed by multiple momentum indicators</p>\n                    <p><strong>9 Jan:</strong> Week closes at ₹8,327.35, down 3.29% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8,611.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.8,327.35</div><div class=\"stat-change negative\">-3.29%</div></div>\n ..."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3781062",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstrazenecaPhar_mojoScore_3781062.png",
        "date": "2026-01-05 08:09:33",
        "description": "Astrazeneca Pharma India Ltd has seen its investment rating downgraded from Hold to Sell as of 2 January 2026, reflecting a shift in technical indicators and valuation metrics despite solid financial performance. The downgrade is primarily driven by a deteriorating technical trend, expensive valuation multiples, and mixed signals from financial and quality parameters, signalling caution for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Mildly Bearish Technical Shift Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-mildly-bearish-technical-shift-amidst-market-pressure-3780930",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstrazenecaPhar_technicaldot_3780930.png",
        "date": "2026-01-05 08:05:52",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early January 2026. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a cautious outlook for investors amid recent price declines and mixed market signals."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-hold-3778890",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AstrazenecaPhar_mojoScore_3778890.png",
        "date": "2026-01-02 10:10:03",
        "description": "Astrazeneca Pharma India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 347,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating",
      "datetime": "02-Feb-2026",
      "details": "Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015",
      "datetime": "31-Jan-2026",
      "details": "Please find the enclosed letter of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.",
      "datetime": "31-Jan-2026",
      "details": "Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1600%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd is Rated Sell

2026-02-07 10:10:48

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Astrazeneca Pharma India Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-02-02 08:04:04

Astrazeneca Pharma India Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a modest day gain of 0.97%, the stock’s technical indicators present a complex picture, with some signals suggesting caution while others hint at potential stabilisation. This article analyses the recent technical parameter changes, key momentum indicators, and how Astrazeneca’s performance compares with broader market benchmarks.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-01-27 10:10:35

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd Gains 0.65%: 2 Key Technical Signals Shape Weekly Trend

2026-01-24 15:07:03

Key Events This Week

Jan 21: Death Cross formation signalling bearish trend

Jan 22: Technical downgrade with Mojo Grade shifting to Sell

Jan 23: Week closes at Rs.8,305.85 (+0.65%) outperforming Sensex

Week Open

Rs.8,251.95

Week Close

Rs.8,305.85

+0.65%

Read full news article

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-01-22 08:01:12

Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.12%, the stock’s broader technical landscape suggests caution for investors amid weakening momentum and mixed signals from key oscillators and moving averages.

Read full news article

Astrazeneca Pharma India Ltd Falls 3.29%: Technical Weakness and Valuation Concerns Shape the Week

2026-01-10 15:04:53

Key Events This Week

5 Jan: Downgrade to Sell rating amid technical weakness and valuation concerns

5 Jan: Mildly bearish technical shift confirmed by multiple momentum indicators

9 Jan: Week closes at ₹8,327.35, down 3.29% for the week

Week Open

Rs.8,611.00

Week Close

Rs.8,327.35

-3.29%

...

Read full news article

Astrazeneca Pharma India Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-01-05 08:09:33

Astrazeneca Pharma India Ltd has seen its investment rating downgraded from Hold to Sell as of 2 January 2026, reflecting a shift in technical indicators and valuation metrics despite solid financial performance. The downgrade is primarily driven by a deteriorating technical trend, expensive valuation multiples, and mixed signals from financial and quality parameters, signalling caution for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Astrazeneca Pharma India Ltd Faces Mildly Bearish Technical Shift Amidst Market Pressure

2026-01-05 08:05:52

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance as of early January 2026. This transition is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a cautious outlook for investors amid recent price declines and mixed market signals.

Read full news article

Astrazeneca Pharma India Ltd is Rated Hold

2026-01-02 10:10:03

Astrazeneca Pharma India Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News